Delapharma SRL
The score of Delapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +26 % Total assets +66 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Delapharma's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 01 Apr 2026
- Year ended 30 Sep 2024filed on 30 Apr 2025
- Year ended 30 Sep 2023filed on 29 Apr 2024
- Year ended 30 Sep 2022filed on 27 Apr 2023
- Year ended 30 Sep 2021filed on 26 Apr 2022
Delapharma's financial analysis
- Solvency35.8%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Delapharma
Delapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0867.801.095
- VAT number
- BE0867801095
- Peppol
- Registered · 0208:0867801095 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Oct 2004
- Registered office
- 8600 Diksmuide
- Latest accounts
- 2025 · filed on 01 Apr 2026
- Activity
- Activities of holding companies (NACE 64210)
Delapharma (SRL) has been based in Diksmuide since 2004, active in: activities of holding companies. For 2025, it reports a net loss of 93,278 € and equity of €1.25m; its revenue is not published. Its solvency stands at 35.8%, below the median of its sector (55.6%).
Companies similar to Delapharma
Companies in the same business, of comparable size and area, outside its group.
- Pladutse Invest Activities of holding companies Ronse · balance sheet €3.50m
- General Chocolates Company Activities of holding companies Nivelles · balance sheet €3.51m
- Rucra Activities of holding companies Ghent · balance sheet €3.51m
- GQ Solutions Activities of holding companies Izegem · balance sheet €3.51m
- Mace Activities of holding companies Edegem · balance sheet €3.50m
- Bnewable Assetco Activities of holding companies Mechelen · balance sheet €3.51m
- Veld Invest Activities of holding companies Izegem · balance sheet €3.49m
- Ginkgo Holdings Activities of holding companies Kampenhout · balance sheet €3.49m
Frequently asked questions about Delapharma
What is the revenue of Delapharma?
Delapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Delapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0867801095 for Delapharma, if the company is VAT-registered. Its company number (CBE) is 0867.801.095.
Where is the registered office of Delapharma?
According to the CBE register, the registered office of Delapharma is in 8600 Diksmuide.
What is the equity of Delapharma?
At the close of the 2025 financial year, the equity of Delapharma amounts to 1,253,043 €, a solvency of 35.8% of total assets.
Who manages Delapharma?
The register lists 2 active mandates at Delapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Delapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →